Related by context. All words. (Click for frequent words.) 69 IAP inhibitor 69 MEK inhibitors 69 BRAF kinase 68 cathepsins 68 humanized monoclonal antibodies 68 antimitotic 67 androgen receptor AR 67 proteasome inhibitors 67 antisense therapies 67 CYT# potent vascular disrupting 67 dasatinib Sprycel 67 inhibit replication 67 siRNA therapeutic 67 serine proteases 66 histone deacetylase HDAC 66 novel peptide 66 MAPK pathway 66 RAS MAPK pathway 66 5 HT2A serotonin 66 M2 subunit 66 adenosine receptor 66 PI3K/mTOR 66 histone deacetylase HDAC inhibitors 66 multitargeted 66 cyclin dependent kinase inhibitor 66 CXCR4 receptor 66 Vidofludimus 66 ENMD # 66 potently inhibit 66 chimeric monoclonal antibody 66 small molecule inhibitors 65 RNA antagonist 65 targeting PCSK9 65 Nanobodies 65 THR beta agonist 65 accumulate preferentially 65 mda 7 65 delta isoform 65 PKC alpha 65 molecularly targeted 65 anticancer therapeutics 65 selective inhibition 65 Smac mimetics 65 biologic therapeutics 65 epothilone 65 sodium glucose transporter 65 tyrosine kinase inhibitor 65 JAK#/JAK# 65 Cdc7 65 CRTH2 65 CCR9 antagonist 65 pro angiogenic 65 DHFR 65 anionic backbone 65 peptibody 65 small molecule tyrosine 65 antisense oligonucleotides 65 LNP formulations 65 telomerase inhibitor 65 Anticalins R 65 thymidylate synthase TS 65 thyroid hormone receptor 64 Locked Nucleic Acid LNA 64 p# MAP kinase 64 Dyax phage display 64 Lyn kinase 64 mTOR inhibitors 64 C5aR 64 signal transduction inhibitor 64 JAK2 enzyme 64 GRNOPC1 contains 64 costimulatory 64 hormone gastrin 64 JAK inhibitors 64 HuLuc# 64 therapeutic monoclonal antibodies 64 FLT3 64 protein kinase inhibitor 64 inhibiting tumor 64 inhibit EGFR 64 Hypoxia Inducible Factor 64 Interferon beta 64 histone methyltransferases HMTs 64 kinase inhibitors 64 histone deacetylation 64 antiangiogenesis 64 apoptosis proteins 64 protein kinase inhibitors 64 A3 adenosine receptor 64 thymidylate synthase 64 p# MAPK 64 RAF kinase 64 siRNA mediated 64 effector functions 64 cytolytic 64 attach auristatin 64 PPARg 64 anticancer therapies 64 potent antiproliferative 64 protein tyrosine phosphatases 64 histone deacetylases 64 prostanoid 64 interferon lambda 64 Notch receptors 64 MEK ERK 64 eIF 4E 64 hedgehog pathway 64 Th2 cytokines 64 HDACs 64 protein tyrosine phosphatase 1B 64 Flt3 64 Protein Kinase C 64 VitiGam 64 selectively inhibit 64 Imatinib mesylate 64 chemokine receptor 64 oncoprotein 64 PTP 1B 64 kidney urologic 64 cytotoxic agents 63 PIK3CA 63 Epothilones 63 vascular disrupting agents 63 peptide antigens 63 imatinib Gleevec ® 63 #beta HSD 1 63 Symadex 63 FGFR3 63 alpha folate receptor 63 oncoproteins 63 adenoviral 63 proteasome inhibitor 63 JAK3 63 vinca alkaloid 63 gastrointestinal stromal tumors GISTs 63 selective kinase inhibitor 63 anti CD3 63 TLR agonists 63 PPARγ 63 SGLT inhibitors 63 glucagon receptor 63 small molecule glucokinase 63 HDAC6 63 CD# expressing 63 enzyme reverse transcriptase 63 mGluR2 NAM 63 Fleximer 63 E#F# 63 NF kB pathway 63 glucocorticoid receptor 63 Notch1 63 deacetylase 63 radionuclide therapy 63 prodrugs 63 TLR8 63 Survivin 63 tubulin binding 63 tumor vasculature 63 RNA antagonists 63 HMG CoA reductase 63 imatinib Gleevec 63 cytoprotective 63 orally bioavailable 63 VEGF receptor 63 histone deacetylase inhibitors 63 ERK1 2 63 mTOR kinase 63 PDGF receptor 63 FGFR 63 humanised antibody 63 NTDDS 63 tyrosine kinase inhibitors 63 Factor Receptor 63 TNFa 63 biomarker identification 63 multi kinase inhibitor 63 HCV protease inhibitors 63 gastro intestinal inflammation 63 EGFR pathway 63 receptor inhibitors 63 humanized antibody 63 siRNA therapeutics 63 PI3K/AKT 63 selectively inhibited 63 oncolytic 63 erlotinib Tarceva 63 c MET 63 IGF 1R 63 ERBB4 63 ERK5 63 4E BP1 63 chemically modified siRNA 63 PLX MS 63 effector function 63 CYC# 63 NS5b 63 NKG2D 63 immunotoxin 63 viral proteins 63 mitotic kinesins 63 antisense inhibitors 63 IGF1R 62 adenosine A2A 62 p# alpha [001] 62 Preclinical studies suggest 62 c MYC 62 PI3K Akt 62 monoclonal antibody MAb 62 protein receptors lectins 62 tubulin inhibitors 62 activate p# 62 inhibit viral replication 62 orally bioavailable mimics 62 immune modulating 62 reversible inhibitor 62 retinoic acid receptor 62 HCV replication 62 proteins peptides 62 HuCAL R 62 thromboxane A2 62 ribonucleotide reductase clinically validated 62 mTOR mammalian target 62 cyclic AMP cAMP 62 ErbB3 62 synthetic peptides 62 EGF receptor 62 HCV polymerase 62 TRAIL induced apoptosis 62 Aurora kinase 62 RAS RAF MEK 62 CCR5 antagonists 62 small molecule activators 62 Kinase inhibitors 62 drug conjugate 62 liposomal formulation 62 VEGF pathway 62 PDE# 62 druggable targets 62 therapeutic monoclonal antibody 62 Fibroblast Growth Factor Receptor 62 receptor tyrosine kinase inhibitor 62 PKM2 62 tyrosine kinase receptor 62 MET amplification 62 Wnt signaling pathway 62 PI3 kinase 62 PARP inhibitors 62 NEUGENE 62 JAK2 inhibitors 62 BCR ABL protein 62 hypereosinophilic syndrome 62 TNFR 62 polysaccharide polymer 62 LSD1 62 5 HT4 62 delipidation 62 HIF 1α 62 selectively induce apoptosis 62 glucokinase 62 NuMimetic TM 62 EGFR inhibitors 62 HSP# inhibitor 62 HER2 receptor 62 NS5A 62 HepDirect R 62 nucleoside analogues 62 miR #a [002] 62 serine threonine kinase 62 Anticalins ® 62 costimulatory molecules 62 ANGPTL4 62 delta gamma agonist 62 PDE4 62 BRAF inhibitors 62 fusion proteins 62 gamma secretase inhibitors 62 dopamine D1 62 sd rxRNA 62 lysosomal 62 specific lectin receptors 62 PDE#A 62 GSK3B 62 MCSP respectively 62 HuCNS SC ® 62 antifolates 62 nicotinic acetylcholine receptor 62 mitogen activated protein kinase 62 EphA2 62 ESBA# 62 humanised antibody designed 62 sd rxRNA compounds 62 MolecularBreeding 62 serine protease 62 novel immunomodulatory 62 mutated Ras 62 small molecule 62 Alfacell proprietary ribonuclease 62 flavopiridol 62 DNA methyltransferases 62 KRAS oncogene 62 tyrosine kinase inhibitor TKI 62 brain penetrant 62 pan HDAC inhibitor 62 aurora kinase 62 CENP E 62 neuronal nicotinic receptors NNRs 62 Treg cell 62 platinum chemotherapeutic 62 muscarinic 62 chemokine 62 MTP inhibitor 62 bispecific 62 cyclophilin D 62 DNA gyrase 62 HDAC inhibitors 62 Enkephalin 62 Fc fusion protein 62 tumor antigens 62 AKT inhibitor 62 peptidic compound 62 COX2 61 CDDO Im 61 apoptotic pathway 61 estrogen receptor beta 61 anti angiogenic drugs 61 CD#b 61 secretory phospholipase A2 61 ddRNAi 61 dihydrofolate reductase 61 SERMs 61 potent inducer 61 Smac mimetic 61 IMiDs 61 NFkB 61 Pertuzumab 61 ALK inhibitors 61 co stimulatory molecules 61 DNA intercalator 61 synthetic siRNA 61 telomerase inhibitors 61 HSP# inhibitors 61 NR2B subunit 61 immune modulators 61 metabolic enzymes 61 induce apoptosis 61 viral polymerase 61 c Raf kinase 61 Archexin 61 IGF IR 61 antisense compounds 61 SGLT2 inhibitors 61 ERK pathway 61 Gleevec resistant 61 endogenous ligands 61 pharmacological chaperone 61 somatostatin 61 anti angiogenic agent 61 γ secretase 61 siRNAs targeting 61 IMiDs R 61 agent VDA 61 protein tyrosine kinase 61 affinity ligands 61 CCR3 61 Cobalamin TM mediated 61 telomerase reverse transcriptase 61 antiapoptotic 61 tubulin inhibitor 61 Tumour Vascular Disrupting Agent 61 HDAC 61 PI3K AKT 61 Monoclonal antibody 61 IgG1 antibody 61 Hedgehog inhibitor 61 carbohydrate compounds 61 acetylcholinesterase AChE 61 cancer immunotherapies 61 HepDirect prodrug 61 tumor antigen 61 mTOR signaling pathway 61 intracellular signaling pathways 61 activin 61 neuro inflammatory 61 PNP inhibitor 61 targeted antifolate 61 potent inhibitors 61 pathophysiological effects 61 CDP# 61 oral kinase inhibitor 61 dihydrofolate reductase DHFR 61 targeting CD# 61 Fleximer R 61 LHRH receptor positive 61 renal fibrosis 61 IL 1β 61 anticancer compounds 61 ENaC 61 Akt1 61 angiogenesis inhibitor 61 oncogenic signaling 61 oral prodrug 61 SIRT2 61 CFTR inhibitors 61 CDK8 61 cellular immunotherapy 61 transmembrane receptor 61 coupled receptor GPCR 61 catalytic antioxidant compounds 61 autoreactive 61 sphingosine 1 61 generation purine nucleoside 61 IFN gamma 61 anti angiogenic agents 61 pleiotropic 61 NS4A 61 CD8 + cytotoxic 61 glucocorticoid receptors 61 rxRNA 61 SIRT1 enzyme 61 Blinatumomab 61 XL# XL# 61 VIPR2 61 potent anticancer 61 cytokine signaling 61 glycosylation profile 61 chemo resistant 61 coreceptor 61 TLR9 agonists 61 lymphoid organs 61 anti fibrotic 61 EGFr 61 selective agonists 61 acadesine 61 kinase PI3K 61 drugable targets 61 Nanobody ® 61 CB2 receptor 61 5 HT2A inverse 61 dependent cellular cytotoxicity 61 mutated p# 61 MEK inhibitor 61 antigenic peptide 61 RNAi compounds 61 PTP1B 61 gefitinib Iressa 61 NKX#.# 61 histone deacetylase 61 Squalamine 61 fusion enhancers 61 Anticalin 61 M1 muscarinic 61 p# inhibitors 61 HDACi 61 kinase inhibitor 61 MDSCs 61 intracellular protein 61 S#P# 61 vanilloid receptor 61 calcitonin gene related 61 endocrine therapies 61 antitumoral 61 CEA CD# Her2 61 epothilones 61 Xencor XmAb 61 oral ghrelin agonist 61 small molecule inhibitor 61 selective modulator 61 signal transduction inhibitors 61 GnT 4a 61 bispecific antibody 61 PORxin TM 61 peptidomimetic 61 phosphate S1P 61 opioid receptor antagonist 61 β catenin 61 targets Galectin receptors 61 myelofibrosis polycythemia vera 61 cytotoxic T lymphocytes 61 diagnostic biomarkers 61 isotypes 61 highly selective inhibitor 61 Kinases 61 VEGF inhibitors 61 volociximab 61 small molecule agonists 61 orally dosed 61 NNRTIs 61 HERV 61 neuroprotective properties 61 shRNAs 61 TRIOLEX HE# 61 potently inhibited 61 ErbB1 61 Wnt beta catenin 61 CoVal TM fusion 61 endosomal release 61 XmAb# 61 protein tyrosine phosphatase 61 casein kinase 61 HDAC2 61 TLR9 agonist 61 immunotherapeutics 60 cMET 60 cellular pathways 60 Xanafide 60 CDK5 60 Pim kinases 60 Akt phosphorylation 60 Intravenous CP 60 protein mTOR 60 IgG1 60 ADCC enhanced 60 peripherally acting 60 #beta HSD1 60 immunotherapeutic approaches 60 selectively binds 60 beta lactamases 60 Tissue Factor 60 protease enzyme 60 proprietary BiTE ® 60 SGLT 2 60 receptor CXCR4 60 non thiazolidinedione TZD 60 fibrotic disease 60 immunomodulatory effects 60 JAK2 60 recombinant adeno associated 60 integrin receptors 60 MSCRAMM ® 60 Epidermal Growth Factor Receptor 60 synthetic retinoid 60 rapamycin mTOR 60 ischemic tissues 60 TNF receptors 60 renin inhibitors 60 cyclin dependent kinases 60 FGFR2 60 preclinical compounds 60 antiangiogenesis therapies 60 EGFR HER 60 Bruton tyrosine kinase 60 CB1 antagonists 60 splice variant 60 TMEM#B 60 lysyl oxidase 60 NF kappaB 60 potent inhibition 60 GPCR targets 60 stable nucleic acid 60 FGFR4 60 PROfusion 60 integrase enzyme 60 nilotinib Tasigna ® 60 T#I [002] 60 SGLT2 60 polymerase inhibitors 60 5 HT2A receptor 60 HER1 60 pyrimidines 60 oral picoplatin 60 potent cytotoxic 60 #HT#A 60 partial agonist 60 intracellular pathway 60 ERK signaling 60 ImmunoGen TAP technology 60 kinase inhibition 60 non porcine pancreatic 60 shRNA libraries 60 antimetabolites 60 ADP receptor antagonist 60 NF kB Decoy 60 suppresses tumor 60 enkephalin 60 LentiVector technology 60 targeted radiotherapeutic 60 nucleoside analog 60 Talabostat 60 Caspases 60 selective receptor agonist 60 #T# L1 60 chemokine SDF 1 60 IMC #B 60 5 HT4 receptor 60 morpholino 60 acetylcholine receptor 60 tests miRview TM 60 polymerase inhibitor 60 liposomal delivery 60 small molecule thrombopoietin 60 Vorinostat 60 polyketide 60 Onconase 60 trans splicing 60 PI3 Kinase 60 apoptotic pathways 60 novel antiviral therapeutics 60 poly ADP ribose polymerase 60 chemotherapeutics 60 Clusterin 60 FGFR1 60 ALK inhibitor 60 recombinant antibodies 60 NS4B 60 serine threonine 60 USP# 60 selectively inhibits 60 histone deacetylase inhibitor 60 histone deacetylases HDACs 60 TTR gene 60 anti angiogenic 60 erlotinib Tarceva ® 60 3 kinase PI3K 60 MMP2 60 cathepsin K inhibitor 60 pRb 60 Poly ICLC 60 selective inhibitors 60 B lymphocyte stimulator 60 inhibit angiogenesis 60 Tyrima 60 extracellular domain 60 preclinically 60 clinically validated targets 60 delay bone metastases 60 AAG geldanamycin analog 60 Locked Nucleic Acid 60 M# rationally 60 KinomeScan 60 humanized monoclonal 60 Aurora Kinase 60 enzyme inhibitor 60 Insegia 60 OncoVex 60 Maxy G# 60 NEUGENE antisense 60 p# subunit 60 Yap1 60 angiogenesis inhibition 60 integrin alpha 4 60 JAK1 60 IMPDH 60 KRAS mutant 60 optical biosensors 60 humanized monoclonal antibody 60 HMGCR 60 PI3K/Akt pathway 60 AEG# 60 inhibit KSP 60 antiproliferative effects 60 autoreactive T cells 60 drug conjugates ADCs 60 TPO receptor 60 pharmacologic approaches 60 microRNA molecules 60 PDE4 inhibitor 60 P#X# 60 antibody mediated 60 RANK ligand 60 Lisofylline 60 SIRT1 gene 60 investigational therapies 60 antisense inhibition 60 Hsp# inhibitors 60 reversible inhibitors 60 antisense drugs 60 U1 Adaptors 60 protein kinases 60 ErbB receptors 60 NFκB 60 Olaparib 60 MorphoSys proprietary 60 secretory pathway 60 5 lipoxygenase 60 Protease inhibitors 60 neurturin 60 anti mitotic 60 metastatic colorectal 60 administered systemically 60 PKCi 60 tumor metastasis 60 tyrosine kinases 60 peroxisome proliferator activated 60 Combivir Kivexa 60 targets EpCAM expressing 60 oncolytic viruses 60 immunoregulation 60 Vandetanib 60 HQK 60 VitiGam TM 60 inhibit metastasis 60 Hsp# inhibition 60 novel immunotherapies 60 PI3K inhibitors 60 chronic eosinophilic leukemia 60 IL #R 60 MAPK signaling pathway 60 IMiDs ® 60 molecular abnormalities 60 5 HT6 60 interleukin IL -# 60 pyruvate kinase 60 novel VDA molecule 60 CD# CEA 60 androgen receptors 60 antibody cytokine 60 IGFBP2 60 osteoclast activity 60 Cyclosert TM 60 lentiviral 60 gastrin 60 metabotropic glutamate receptors 60 microtubule inhibitor 60 CARBOSOME TM formation 60 Tumor Necrosis Factor 60 Aurora kinases 60 Umbilical cord stem cells 60 IMA# 60 effector cells 60 panitumumab Vectibix 60 IMiDs ® compound 60 trastuzumab Herceptin 60 HuMax TAC 60 CDK4 60 therapeutic peptide 60 MDM2 60 HER3 60 pancreatic islet beta 60 proprietary polysaccharide 60 therapeutic mAbs 60 engineered proteases 60 lipid nanoparticle 60 TGF b 60 CEACAM1 60 non nucleoside 60 anti CD3 monoclonal 60 OGG1 60 lung pancreatic 60 glycolipids 60 CCR2 60 XmAb TM 60 immune effector 60 orally administered inhibitor 60 Eg5 60 aldose reductase 60 humanized therapeutic 60 secreted protein 60 transduce 60 Ii protein 60 CobaCyte 60 short interfering RNA 60 topoisomerase II 59 Sphingomab 59 secreted proteins 59 SOD1 gene 59 chaperone protein 59 BCL2 59 oncogenesis 59 Panzem 59 intracellular pathways 59 siRNA sequences 59 cardio metabolic diseases 59 metaglidasen 59 glial derived neurotrophic 59 p# deficient 59 lysophosphatidic acid LPA 59 Gefitinib 59 CD# antibodies 59 kinase pathway 59 neurite outgrowth 59 glioma cells 59 antisense oligonucleotide 59 CDK cyclin dependent 59 cyclooxygenase COX 59 CRAC channel 59 costimulation 59 Alnylam RNAi 59 Monoclonal antibodies 59 p# activation 59 anti gastrin monoclonal 59 AGTR1 59 PAM4 59 FKBP# 59 IKK2 59 enzymatic pathways 59 K ras mutations 59 p#INK#a 59 immunomodulation 59 lentiviral vectors 59 B Raf 59 ALN TTR 59 oncolytic virus therapies 59 vidofludimus 59 DGAT1 59 vaccine GRNVAC1 59 granzyme B 59 immunomodulatory 59 LEX System 59 prostaglandin synthesis 59 insulin sensitizing 59 CCL# 59 ghrelin antagonist 59 FGFs 59 eotaxin 59 stimulate insulin secretion 59 pancreatic endocrine 59 Affibody ® molecules 59 immunoregulatory 59 coupled receptors GPCRs 59 Virulizin ® 59 NF κB 59 neuroinflammation 59 ADAM# 59 non coding RNA 59 toxic misfolded proteins 59 paxillin 59 selective kinase inhibitors 59 NF KB 59 monoclonals 59 tumor suppressive 59 VEGF receptors 59 ADAMTS# 59 signaling cascades 59 Interferon alpha 59 RNAi therapeutic targeting 59 transgenic rats 59 tNOX 59 tkRNAi technology 59 alpha 2A 59 type glutamate receptor 59 Factor VIIa 59 cyclophilin inhibitors 59 predictive biomarkers 59 autocrine 59 BCR ABL 59 TGF ß 59 potent inhibitory 59 TORC2 59 XL# XL# XL# XL# 59 pathological hallmarks 59 AT1R 59 PDGFR 59 p# pathway 59 TAT# 59 PI3K signaling pathway 59 beta catenin pathway 59 Hedgehog pathway 59 melanocortin receptor 59 c KIT 59 Anticalin ® 59 Akt signaling 59 Cathepsin B 59 CD# ligand 59 molecular biomarkers 59 cyclin dependent kinase CDK 59 taxane derivative 59 triggers apoptosis programmed 59 leukemias lymphomas 59 heterologous 59 Histone deacetylase 59 Receptors GPCRs 59 radiolabeled antibodies 59 Dystrophin 59 Rigel R# 59 TNFα 59 Nasdaq IMGN biotechnology 59 CHD5 59 methylated DNA 59 mTORC1 59 UCP2 59 DepoVax ™ 59 selective immunoproteasome inhibitor 59 R roscovitine 59 potently inhibits 59 glycosylated 59 macrocyclic lactone 59 ribonuclease 59 MUC1 protein 59 Syk 59 mimetics 59 receptor inhibitor 59 TNF alpha antagonist 59 TH# cells 59 INT# [002] 59 enhance ApoA 59 innate immune responses 59 xenograft models 59 acetylcholinesterase 59 TGF alpha 59 Topoisomerase II 59 insulin sensitizers 59 CBLC# 59 beta adrenergic receptors 59 viral antigens 59 tumorigenicity 59 Maribavir 59 Anticalins 59 immunomodulating 59 deacetylase inhibitors 59 PKC isoforms 59 detection reagents 59 antimetabolite 59 methyl D aspartate 59 ERa 59 highly selective endothelin 59 myeloma cells 59 HDAC enzymes 59 mitotic kinesin 59 phosphorylate 59 cholesteryl ester transfer 59 GSK3 59 GGTase 59 Smoothened 59 DOS# 59 selective agonist 59 Zolinza 59 isoform selective inhibitors 59 HIF 1a 59 UsiRNAs 59 plasminogen 59 intracellular signaling 59 androgen receptor signaling 59 CDK inhibitors 59 pharmacologic agents 59 splice variants 59 EGFR HER2 59 TRIOLEX HE# APOPTONE HE# 59 vaccines oncolytic virus 59 cyclin dependent kinases CDKs 59 mutated K ras 59 isoform selective 59 GVAX ® 59 antiviral therapies 59 Marqibo TM 59 rhIL 7 59 MMAE 59 dAbs 59 XmAb 59 short hairpin RNAs 59 anti amnesic 59 Deforolimus 59 novel anticancer 59 DsiRNA 59 monoclonal antibody mAb 59 antiangiogenic agent 59 HuMax 59 CXCL5 59 interferon IFN 59 fatty acid biosynthesis 59 maturation inhibitors 59 FTIs 59 mAbs 59 cathepsin K 59 XL# anticancer compounds 59 DGAT1 inhibitors 59 Galectin 59 glutamate receptors 59 kinesin spindle protein 59 ZNF# 59 anticoagulant reversing agent 59 STK# [002] 59 prolyl hydroxylase inhibitors 59 factor Xa 59 cyclooxygenase 59 immune modulatory 59 antisense drug 59 membrane receptors 59 D aspartate NMDA receptor 59 SCD1 59 FVIIa 59 molecularly targeted therapy 59 biased ligand 59 inhibitory neurotransmitters 59 CCR5 antagonist 59 chemokine receptors 59 HbF 59 receptor subtypes 59 inverse agonist 59 Ras MAPK pathway 59 Exelixis compounds 59 tyrosine kinase 59 Carcinoid tumors 59 Pentad TM 59 Transcription factors 59 Delta opioid receptor 59 lymphangiogenesis 59 NS#/#A protease 59 selective inhibitor 59 hypoxia inducible factor 59 TRPV1 agonist 59 BiTE 59 Tumor necrosis factor 59 Azedra 59 antitumor 59 oncogenic transformation 59 thalidomide Thalomid 59 monocytes macrophages 59 OMP #M# 59 CCR5 inhibitors